Employers push health savings plans, nutritional counseling to avoid GLP-1 coverage for weight loss
Cost remains a major factor for employers as the popular drug for weight loss represented 11.4% of annual claims for corporations in 2025.
Read the full articleYou might also wanna read
A Record 40 Million Americans Are Now Taking GLP-1 Weight-Loss Drugs as Medicare Coverage Begins
A Gallup survey shows 11% of Americans now take GLP-1 drugs for weight loss as Medicare begins covering them for $50 monthly. Here's what it
How many Canadian employers are offering GLP-1 coverage for weight loss?
Cost control, eligibility requirements, and health risks of obesity among key factors shaping employer approach to medication: IFEBP survey
CVS Health CEO says employer health plans can't afford GLP-1 weight loss drug costs
The corporations that pay for private employee health insurance are not ready to swallow the high costs of the enormously popular drugs, sai
washingtonpost.com·4d ago
Nearly one in 10 Britons use or want weight-loss medication
The prevalence of GLP-1 receptor agonists for weight management in Great Britain highlights public interest and concerns over safety and pre
GLP-1 Drug Use Triples In Two Years As American Obesity Rate Falls, Gallup Finds
A new Gallup survey reveals that 11% of U.S. adults currently take GLP-1 medications for weight loss, a sharp rise from just 3% in 2024. The
Medicare begins covering weight-loss medications: who qualifies and how the new program will work
A pilot program will, for the first time, allow millions of beneficiaries to access GLP-1 medications to treat obesity with a monthly copay
Comments
Sign in to join the conversation.
No comments yet. Be the first.